drugset / Trial / NCT00761137

Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients

NCT00761137

RandomizedCrossoverQuadruple-blindTreatment

Summary

The primary goal of the study is to evaluate the safety and potential efficacy of intra-oral dissolvable NH004 films to improve the short-term symptoms of sialorrhea (drooling) in Parkinson's disease (PD) patients.

Timeline

Start
2008-03
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject tropicamide Small molecule 0.3 mg Other
Subject tropicamide Small molecule 1 mg Other
Subject tropicamide Small molecule 3 mg Other